24 Facts About Bob Langer

Bob Langer was formerly the Germeshausen Professor of Chemical and Biomedical Engineering and maintains activity in the Department of Chemical Engineering and the Department of Biological Engineering at MIT.

Bob Langer is a widely recognized and cited researcher in biotechnology, especially in the fields of drug delivery systems and tissue engineering.

Bob Langer has been awarded numerous leading prizes in recognition of his work.

Bob Langer is an alumnus of The Milne School and received his bachelor's degree from Cornell University in chemical engineering.

Bob Langer's dissertation was entitled "Enzymatic regeneration of ATP" and completed under the direction of Clark K Colton.

Related searches

Bob Langer is widely regarded for his contributions to medicine and biotechnology.

Bob Langer is considered a pioneer of many new technologies, including controlled release systems and transdermal delivery systems, which allow the administration of drugs or extraction of analytes from the body through the skin without needles or other invasive methods.

Bob Langer worked with Judah Folkman at Boston Children's Hospital to isolate the first angiogenesis inhibitor, a macromolecule to block the spread of blood vessels in tumors.

Bob Langer's idea was to encapsulate the angiogenesis inhibitor in a noninflammatory synthetic polymer system that could be implanted in the tumor and control the release of the inhibitor.

Bob Langer worked with Henry Brem of the Johns Hopkins University Medical School on a drug-delivery system for the treatment of brain cancer, to deliver chemotherapy directly to a tumor site.

Bob Langer is regarded as the founder of tissue engineering in regenerative medicine.

Bob Langer is part of a team at MIT that have developed a drug capsule that could be used to deliver oral doses of insulin to people with type 1 diabetes.

Bob Langer is the youngest person in history to be elected to all three American science academies: the National Academy of Sciences, the National Academy of Engineering and the National Academy of Medicine.

Bob Langer was elected as a charter member of National Academy of Inventors.

Bob Langer was elected as an International Fellow of the Royal Academy of Engineering in 2010.

Bob Langer is one of three living individuals to have received both the U S National Medal of Science and the National Medal of Technology and Innovation.

Bob Langer has given 137 named lectures and commencement speeches.

Bob Langer has honorary degrees from 37 universities from around the world including Harvard, Yale, and Columbia University.

Robert Bob Langer has been involved in the founding of many companies, more than twenty in partnership with the venture capital firm Polaris Partners.

Success of these companies and Bob Langer's contribution has been detailed by Harvard Business Review:.

Bob Langer is a member of the Advisory Board of Patient Innovation, a nonprofit, international, multilingual, free venue for patients and caregivers of any disease to share their innovations.

Bob Langer is a member of the Xconomists, an ad hoc team of editorial advisors for the tech news and media company, Xconomy.

Bob Langer is featured in two different exhibits at Boston's Logan Airport.

In terminal E, Massachusetts innovators-Transforming the world, Bob Langer is featured as "Revolutionary Biomedical Technology through Development of Controlled Drug Delivery Systems" .